Status:
COMPLETED
Study of Freeze-dried Black Raspberry in Maintenance of Ulcerative Colitis
Lead Sponsor:
UConn Health
Collaborating Sponsors:
Medical College of Wisconsin
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-90 years
Phase:
PHASE1
Brief Summary
This research study is about adding Black Raspberry powder to the treatment regimen of patients with ulcerative colitis who are currently in remission and doing well.
Eligibility Criteria
Inclusion
- Adult patients (\>18 years of age) with known diagnosis of ulcerative colitis who are currently in remission on a stable dose of 5-ASA products and/or steroids (equivalent to prednisone 20 mg or less). English speaking/reading male or female patients from all ethnicities will be considered for the study.
Exclusion
- Treatment with Immunomodulators and/or biologic agents, active disease flare, patients younger than 18 years old, patients who are pregnant or trying to get pregnant, breast feeding and those with reported history of allergy or hypersensitivity to berry products.
- Patients who are using NSAIDS will also be excluded from the study but low dose ASA (81-162 mg) is permitted if needed.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 13 2015
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT02267694
Start Date
August 1 2013
End Date
November 13 2015
Last Update
April 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Connecticut Health Center
Farmington, Connecticut, United States, 06030-1845